About US
Contact us
-
Fujifilm socks $2B into new U.S. site as its global CDMO ambitions take shapeSeeking todramatically bolster its position in the contract development and manufacturing business, Fujifilm isinvesting$2 billion on a large cell culture production site in the U.S. The site will fe2021/1/8
-
Pfizer, AbbVie, BMS, Teva, Sanofi, Gilead and others ring in 2021 with nearly 600 price hikesPharma's routine January price hikes are here once again—and not even a global pandemic seems to be slowing thenumberof increases. Amid ongoingscrutiny from politicians and the public, though, the2021/1/5
-
Judge blocks Trump's 'most favored nation' drug pricing ruleWelcome to theFiercePharmapolitical roundup, where each Monday we’ll highlight developments that could affect drug pricing and howdrugmakersoperate. While the holiday season often brings a lul2021/1/5
-
Pfizer, feds ink another COVID-19 vaccine supply deal for 100M dosesAfter an initial coronavirus vaccine supply deal inked this summer and a tense back-and-forth last week between the federal government and Pfizer, the two sides have forged another supply agreement.2020/12/31
-
AstraZeneca now has a 'winning formula' for its COVID-19 vaccine, CEO saysAstraZeneca's early COVID-19 trial data not only fell short of Pfizer and Moderna's expectation-beating stats, they raised a host of questionsthanks to a dosing error in one group of trial patients.2020/12/31
-
Moderna’s Covid-19 vaccine obtains Health Canada authorisationModerna has received authorisation for its Covid-19 vaccine from Health Canada for the immunisation of individuals aged 18 years and above. Co-developed by Moderna and NIAID Vaccine Research Center i2020/12/30
-
FDA investigates allergic reactions of Pfizer Covid-19 vaccine in USThe US Food and Drug Administration (FDA) has started investigating around five allergic reactions that occurred after individuals received Pfizer and BioNTech’s Covid-19 shot. Last week,FDA authoris2020/12/30
-
Takeda to divest non-core assets to Hasten Biopharmaceutic for $322mTakeda Pharmaceutical Company has signed an agreement to divest a portfolio of five non-core prescription pharmaceutical assets sold in China to Hasten Biopharmaceutic for $322m. Hasten will gain the2020/12/29
-
Dr. Reddy’s seeks approval from Health Canada for Covid-19 treatmentDr. Reddy’s Canada has filed an application with Health Canada on behalf of the consortium for Reeqonus (favipiravir) tablets for acute treatment of mild to moderate Covid-19 in adult patients. The s2020/12/28
-
Pfizer, Moderna urge calm as they launch tests of vaccines against mutated COVID-19After a mutated, fast-spreading variant of COVID-19 in the U.K. disrupted global travel over the weekend, a troubling question emerged: Will the new vaccines from Pfizer and Moderna work against this2020/12/25